Literature DB >> 12444921

Genomic organization and transcriptional analysis of the human l-glutaminase gene.

Cristina Pérez-Gómez1, José M Matés, Pedro M Gómez-Fabre, Antonio del Castillo-Olivares, Francisco J Alonso, Javier Márquez.   

Abstract

In mammals, glutaminase (GA) is expressed in most tissues, but the regulation of organ-specific expression is largely unknown. Therefore, as an essential step towards studying the regulation of GA expression, the human liver-type GA (hLGA) gene has been characterized. LGA genomic sequences were isolated using the genome walking technique. Analysis and comparison of these sequences with two LGA cDNA clones and the Human Genome Project database, allowed the determination of the genomic organization of the LGA gene. The gene has 18 exons and is approx. 18 kb long. All exon/intron junction sequences conform to the GT/AG rule. Progressive deletion analysis of LGA promoter-luciferase constructs indicated that the core promoter is located between nt -141 and +410, with several potential regulatory elements: CAAT, GC, TATA-like, Ras-responsive element binding protein and specificity protein 1 (Sp1) sites. The minimal promoter was mapped within +107 and +410, where only an Sp1 binding site is present. Mutation experiments suggested that two CAAT recognition elements near the transcription-initiation site (-138 and -87), play a crucial role for optimal promoter activity. Electrophoretic mobility-shift assays confirmed the importance of CAAT- and TATA-like boxes to enhance basal transcription, and demonstrated that HNF-1 motif is a significant distal element for transcriptional regulation of the hLGA gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12444921      PMCID: PMC1223212          DOI: 10.1042/BJ20021445

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing.

Authors:  K M Elgadi; R A Meguid; M Qian; W W Souba; S F Abcouwer
Journal:  Physiol Genomics       Date:  1999-08-31       Impact factor: 3.107

2.  Identification of an mRNA-binding protein and the specific elements that may mediate the pH-responsive induction of renal glutaminase mRNA.

Authors:  O F Laterza; W R Hansen; L Taylor; N P Curthoys
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

3.  Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

Authors:  T Nagase; K Ishikawa; M Suyama; R Kikuno; M Hirosawa; N Miyajima; A Tanaka; H Kotani; N Nomura; O Ohara
Journal:  DNA Res       Date:  1998-12-31       Impact factor: 4.458

Review 4.  Relevance of glutamine metabolism to tumor cell growth.

Authors:  M A Medina; F Sánchez-Jiménez; J Márquez; A Rodríguez Quesada; I Núñez de Castro
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

5.  Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-type glutaminase.

Authors:  E M Smith; M Watford
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

6.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

7.  Alu sequences in the coding regions of mRNA: a source of protein variability.

Authors:  W Makałowski; G A Mitchell; D Labuda
Journal:  Trends Genet       Date:  1994-06       Impact factor: 11.639

8.  Identification of two human glutaminase loci and tissue-specific expression of the two related genes.

Authors:  J C Aledo; P M Gómez-Fabre; L Olalla; J Márquez
Journal:  Mamm Genome       Date:  2000-12       Impact factor: 2.957

9.  Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

Authors:  C Lobo; M A Ruiz-Bellido; J C Aledo; J Márquez; I Núñez De Castro; F J Alonso
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

10.  Three clustered Sp1 sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat.

Authors:  Y R Boisclair; A L Brown; S Casola; M M Rechler
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

View more
  11 in total

1.  Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.

Authors:  Larissa Menezes Dos Reis; Douglas Adamoski; Rodolpho Ornitz Oliveira Souza; Carolline Fernanda Rodrigues Ascenção; Krishina Ratna Sousa de Oliveira; Felipe Corrêa-da-Silva; Fábio Malta de Sá Patroni; Marília Meira Dias; Sílvio Roberto Consonni; Pedro Manoel Mendes de Moraes-Vieira; Ariel Mariano Silber; Sandra Martha Gomes Dias
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

Review 2.  Glutamate and Brain Glutaminases in Drug Addiction.

Authors:  Javier Márquez; José A Campos-Sandoval; Ana Peñalver; José M Matés; Juan A Segura; Eduardo Blanco; Francisco J Alonso; Fernando Rodríguez de Fonseca
Journal:  Neurochem Res       Date:  2016-12-23       Impact factor: 3.996

3.  Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function.

Authors:  Wenwei Hu; Cen Zhang; Rui Wu; Yvonne Sun; Arnold Levine; Zhaohui Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-08       Impact factor: 11.205

4.  Co-expression of glutaminase K and L isoenzymes in human tumour cells.

Authors:  Cristina Pérez-Gómez; José A Campos-Sandoval; Francisco J Alonso; Juan A Segura; Elisa Manzanares; Pedro Ruiz-Sánchez; María E González; Javier Márquez; José M Matés
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

5.  High-Throughput Screening Reveals New Glutaminase Inhibitor Molecules.

Authors:  Renna K E Costa; Camila T Rodrigues; Jean C H Campos; Luciana S Paradela; Marilia M Dias; Bianca Novaes da Silva; Cyro von Zuben de Valega Negrao; Kaliandra de Almeida Gonçalves; Carolline F R Ascenção; Douglas Adamoski; Gustavo Fernando Mercaldi; Alliny C S Bastos; Fernanda A H Batista; Ana Carolina Figueira; Artur T Cordeiro; Andre L B Ambrosio; Rafael V C Guido; Sandra M G Dias
Journal:  ACS Pharmacol Transl Sci       Date:  2021-12-01

6.  Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.

Authors:  Mercedes Martín-Rufián; Renata Nascimento-Gomes; Ana Higuero; Amanda R Crisma; José A Campos-Sandoval; María C Gómez-García; Carolina Cardona; Tzuling Cheng; Carolina Lobo; Juan A Segura; Francisco J Alonso; Monika Szeliga; Jan Albrecht; Rui Curi; Javier Márquez; Alison Colquhoun; Ralph J Deberardinis; José M Matés
Journal:  J Mol Med (Berl)       Date:  2013-11-26       Impact factor: 4.599

7.  Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism.

Authors:  Mercedes Martín-Rufián; Marta Tosina; José A Campos-Sandoval; Elisa Manzanares; Carolina Lobo; J A Segura; Francisco J Alonso; José M Matés; Javier Márquez
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

8.  Interferon-α regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disorders.

Authors:  Lixia Zhao; Yunlong Huang; Changhai Tian; Lynn Taylor; Norman Curthoys; Yi Wang; Hamilton Vernon; Jialin Zheng
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma.

Authors:  Juan Liu; Cen Zhang; Meihua Lin; Wei Zhu; Yingjian Liang; Xuehui Hong; Yuhan Zhao; Ken H Young; Wenwei Hu; Zhaohui Feng
Journal:  Oncotarget       Date:  2014-05-15

10.  STAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophages.

Authors:  Lixia Zhao; Yunlong Huang; Jialin Zheng
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.